Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. INTS

Stock Price & Analysis

-
stocks logo
INTS
-
$
0.000
0.000(0%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

INTS Stock Price Chart

5D
1M
3M
6M
YTD
1Y
5Y

INTS Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

INTS Company Profile

banner

INTS Technical Analysis

Instant technical analysis with one click on any asset

banner

INTS Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy INTS

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

INTS News Sentiment

AI uncovers potential trading opportunities based on news sentiment

banner

INTS Technical Analysis

Instant technical analysis with one click on any asset

banner

INTS Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy INTS

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

INTS News Sentiment

AI uncovers potential trading opportunities based on news sentiment

INTS Fundamental Analysis

Moderate Buy
Buy
Hold
Sell
bubble
High
bubble
Averages
bubble
Low
Analyst
Rating
Action
Price Target
Date
Rating Reason

INTS News

INTS FAQs

What is surpport and resistant level for INTS Stock?

The S1 support level for INTS Stock is $2.06 ,The R1 resistant level for INTS Stock is $2.61.

What is the current price of INTS Stock?

As of the end of day on 2025-02-06, the price of INTS Stock was $2.428.

What is the target price of INTS Stock?

The target price for INTS Stock according to analyst rating is 6.75, with the highest price target at 8.50 and the lowest at 5.00. Analysts have a Moderate Buy rating on INTS Stock overall.

What is the market cap of Intensity Therapeutics Inc?

The market cap of INTS is $35.5M.

What is Intensity Therapeutics Inc (INTS)'s business?

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to treat solid tumor cancers. It leverages its DfuseRx technology platform to create proprietary drug formulations. Its product candidates have the potential to induce an adaptive immune response that attacks the injected and non-injected tumors. The Company's lead product candidate, INT230-6, is in development for the treatment of patients with solid tumors, such as sarcoma and breast cancer patients. The Company, through Merck Sharpe & Dohme (Merck), evaluates INT230-6 with pembrolizumab. In addition, it also evaluates the combination INT230-6 with Bristol-Myers Squibb's anti-CTLA-4 antibody, ipilimumab. It also has an agreement with the Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research to study INT230-6 in a randomized controlled neoadjuvant phase II study in women with early-stage breast cancer (the INVINCIBLE study) (NCT04781725).

How many employees does INTS have?

INTS has a total of 5 employees.

INTS Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

INTS Company Profile

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free